当前位置: 首页 >> 检索结果
共有 1981 条符合本次的查询结果, 用时 1.3079696 秒

1. The effectiveness of combining ursodeoxycholic acid with vitamin D in treating patients with primary biliary cholangitis and its impact on hepatic fibrosis: a randomized trial.

作者: Yilihamu Abulitifu.;Mierzhati Maimaiti.;Fengcong Zhao.;Munire Adilijiang.;Wen Qian.;Yongping Zhang.
来源: BMC Gastroenterol. 2025年25卷1期525页
To investigate the effectiveness of combining ursodeoxycholic acid (UDCA) and vitamin D (VitD) in treating patients with primary biliary cholangitis (PBC) and its impact on hepatic fibrosis.

2. Endobiliary radiofrequency ablation in recurrence and unresectable Perihilar cholangiocarcinoma.

作者: Apiwat Jareanrat.;Vasin Thanasukarn.;Tharatip Srisuk.;Vor Luvira.;Theerawee Tipwaratorn.;Anucha Ahooja.;Watcharin Loilome.;Piya Prajumwongs.;Attapol Titapun.
来源: BMC Gastroenterol. 2025年25卷1期501页
Palliative biliary stenting is the principal treatment for unresectable perihilar cholangiocarcinoma (pCCA) patients with jaundice. Endobiliary radiofrequency ablation (EBRFA) is a novel treatment used in combination with biliary stenting for CCA, aiming to prolong stent patency and patient survival. However, the evidence regarding its safety and efficacy in perihilar CCA remains limited. This study aims to investigate the safety of EBRFA and efficacy in terms of increasing stent patency and the patient's survival.

3. Clinical application of pre-rehabilitation concept on comfort colonoscopy in Chinese elderly patients: a randomised controlled trial.

作者: Lun Zhang.;Xiaoling Lv.;Qin Zhu.;Jianying Zhou.;Hanlei Huang.;Yiqian Huang.;Caijuan Si.
来源: BMC Gastroenterol. 2025年25卷1期457页
The concept of pre-rehabilitation has been clinically implemented across various surgical fields; however, studies investigating its application in colonoscopy remain limited. This study aimed to evaluate the effectiveness, safety, and patient satisfaction of the pre-rehabilitation concept in bowel preparation for comfort colonoscopy among elderly Chinese patients.

4. Prospective randomized, placebo-controlled study: role of branched-chain amino acids infusion as adjunct therapy post-liver surgery for patients in the intensive care unit.

作者: Eman Ibrahim El-Desoki Mahmoud.;Faten Farid Awdallah.
来源: BMC Gastroenterol. 2025年25卷1期439页
Several animal studies have shown that Branched-chain amino acids (BCAAs) may prevent acute liver injury, although its effects in humans are as yet undetermined. Thus the purpose of this study is to evaluate the impact of intravenous BCAAs infusion on liver profile post-liver surgery in the intensive care unit (ICU).

5. Effectiveness of an app-based walking program for obese patients with inflammatory bowel disease in Korea: a single-blind parallel-group randomized clinical trial.

作者: Young Jin Lee.;Eun Ja Kwon.;Da-In Park.;Sang Hyoung Park.;Sung Wook Hwang.;Byong Duk Ye.
来源: BMC Gastroenterol. 2025年25卷1期417页
Obesity in patients with inflammatory bowel disease (IBD) not only exacerbates symptoms but also interferes with treatment and leads to additional complications. Therefore, managing weight loss and preventing obesity are crucial. This study was designed to develop and implement a 10-week walking exercise program, facilitated by a mobile application, to evaluate its effectiveness in managing weight in obese IBD patients.

6. The effect of chewing gum on postoperative ileus after laparotomy for gastroduodenal perforations: a randomized controlled trial.

作者: Joshua Muhumuza.;Selamo F Molen.;Godefroy N Bassara.;Musa A Waziri.;Stephen M Kithinji.;Kiyaka M Sonye.;Mugisho M Leocadie.;ByaMungu P Kagenderezo.;Esperant T Tshimanga.;Tatana M Faustin.;Herman Lule.
来源: BMC Gastroenterol. 2025年25卷1期402页
Prolonged postoperative ileus is linked to a higher risk of additional complications, longer hospital stays, and higher healthcare expenses. There are few randomized controlled trials on the impact of chewing gum on the duration of ileus in patients undergoing emergency surgery, notably those with peritonitis. Compelling evidence from studies on elective procedures demonstrates that chewing gum can lessen the duration of ileus. This trial aimed to examine the effect of chewing gum on the length of the postoperative ileus which develop after laparotomy for gastroduodenal perforations.

7. Eradication of Helicobacter pylori that contributes to hepatogenic ulcer is beneficial to the healing of hepatogenic ulcer.

作者: Guanen Qiao.;Le Feng.;Meng Wang.;Chaoyang Wang.;Changjuan Li.;Shuxiang Han.;Yanmei Wang.;Shubo Li.;Shuanli Xin.
来源: BMC Gastroenterol. 2025年25卷1期359页
This study aimed to explore the role of Helicobacter pylori (Hp) eradication in patients with hepatogenic ulcer (HU).

8. A randomized, controlled trial of oral sulfate solution versus polyethylene glycol for bowel preparation for colonoscopy.

作者: Dong-Ling Xie.;Jin-Hui Fan.;Chan-Juan Fan.;Ying-Hui Gao.;Jian-Ping Cheng.
来源: BMC Gastroenterol. 2025年25卷1期292页
The quality of colonoscopy is significantly influenced by the effectiveness of bowel preparation. In this study, we aimed to evaluate the efficacy, safety, and tolerability of bowel cleansing between a new oral sulfate solution (OSS) and standard polyethylene glycol electrolyte powder (PEG).

9. Comparative effects of aerobic and resistance exercise on bile acid profiles and liver function in patients with non-alcoholic fatty liver disease.

作者: Jiasen Shi.;Junchao Cui.;Tianlei Zheng.;Xiaoping Han.;Bin Wang.;Wenjing Wang.;Chenggang Zhu.;Chenle Fang.;Xueyan Zhou.;Ning Cong.;Xiaoxing Yin.;Qiang Yang.
来源: BMC Gastroenterol. 2025年25卷1期239页
Our research aims to explore the effects of different exercise on liver function and bile acid in patients with non-alcoholic fatty liver disease (NAFLD), to identify the most beneficial exercise modalities for patients with NAFLD.

10. The impact of refined nursing management on the diagnosis of early gastric cancer under ME-NBI.

作者: Yi Fan.;Ming Ma.;Qing Liu.;Yu Wu.
来源: BMC Gastroenterol. 2025年25卷1期225页
To explore the impact of magnifying endoscopy with narrow-band imaging (ME-NBI) combined with refined nursing management on the endoscopic diagnosis of early gastric cancer.

11. A randomized open label pilot study evaluating the efficacy of two dosing regimens of rifamycin SV MMX in the treatment of small intestinal bacterial overgrowth.

作者: Bradley A Connor.;Marina Rogova.;Jefferson Garcia.;Morgan Gardner.;Charandeep Waraich.;Victoria Averill.
来源: BMC Gastroenterol. 2025年25卷1期219页
Antibiotics have demonstrated efficacy in the eradication of the underlying overgrowth bacteria and improvement of symptoms of small intestinal bacterial overgrowth (SIBO). The use of standard antibiotics may cause intolerable side effects such as development of multidrug-resistant enteric bacteria, Clostridioides difficile infections and dysbiosis. Nonabsorbable antibiotics have the advantage of minimized side effects. Rifaximin, an antibiotic of the ansamycin class has been shown to be effective in the treatment of SIBO. We evaluated the use of another ansamycin antibiotic, rifamycin SV MMX (AEMCOLO) in the treatment of SIBO. One difference from rifaximin is the site of delivery of AEMCOLO which appears to be the distal small intestine and colon. Hence by maintaining the microbial milieu of the proximal small intestine, the clearance of the overgrowth bacteria might be enhanced. The side effect profile of Rifamycin SV MMX has been described elsewhere in the pivotal trials; there were no safety signals noted in this study. This randomized open label pilot study evaluated the efficacy of two dosing regimens of AEMCOLO in treating SIBO. We used a simple randomization method to assign participants into study groups. The participants included 31 patients, split between two treatment arms: one receiving the medication twice daily and the other - three times daily. The outcomes were assessed based on symptom improvement and breath test normalization. The results indicated a beneficial response with both dosing regimens leading to symptom improvement and breath test normalization. Further evaluation revealed that in the three-time daily regimen, greater symptomatic improvement was observed. For clinicians treating SIBO, this study suggests that AEMCOLO is a viable treatment option. A double-blind, placebo-controlled design will probably be necessary to ascertain the true efficacy of different dosing regimens of AEMCOLO in treating SIBO.

12. Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants With Moderately to Severely Active Crohn's Disease: Results From the Phase 3 GRAVITI Study.

作者: Ailsa Hart.;Remo Panaccione.;Flavio Steinwurz.;Silvio Danese.;Tadakazu Hisamatsu.;Qian Cao.;Timothy Ritter.;Ursula Seidler.;Mobolaji Olurinde.;Marion L Vetter.;Jacqueline Yee.;Zijiang Yang.;Yuhua Wang.;Jewel Johanns.;Chenglong Han.;Aparna Sahoo.;Natalie A Terry.;Bruce E Sands.;Geert D'Haens.; .
来源: Gastroenterology. 2025年169卷2期308-325页
Subcutaneous (SC) induction and maintenance with guselkumab was evaluated in adult participants with moderately to severely active Crohn's disease.

13. The Efficacy of Texture and Color Enhancement Imaging Observation in the Detection of Colorectal Lesions: A Multicenter, Randomized Controlled Trial (deTXIon Study).

作者: Naoya Toyoshima.;Taku Sakamoto.;Kensuke Shinmura.;Kinichi Hotta.;Masashi Misawa.;Naoto Tamai.;Toshio Uraoka.;Takahisa Matsuda.;Taro Shibata.;Yasuhiko Mizuguchi.;Hiroyuki Takamaru.;Keiko Nakamura.;Yasuo Kakugawa.;Mamiko Shiroyama.;Ryosuke Kawagoe.;Kiichiro Tsuchiya.;Hiroaki Ikematsu.;Atsushi Inaba.;Nobuhisa Minakata.;Kenichiro Imai.;Kazunori Takada.;Sayo Ito.;Kunihiko Wakamura.;Shin-Ei Kudo.;Kazuki Sumiyama.;Mamoru Ito.;Shota Tomaru.;Ai Fujimoto.;Yutaka Saito.
来源: Gastroenterology. 2025年169卷2期337-345.e2页
Colonoscopy is the gold standard for detecting and resecting adenomas and early-stage cancers to reduce colorectal cancer (CRC) incidence and mortality rates. This study aimed to confirm the superiority of texture and color enhancement imaging (TXI) over white light imaging (WLI) in detecting colorectal lesions.

14. Capsule Endoscopy-Guided Proactive Treat-to-Target Versus Continued Standard Care in Patients With Quiescent Crohn's Disease: A Randomized Controlled Trial.

作者: Shomron Ben-Horin.;Adi Lahat.;Bella Ungar.;Offir Ukashi.;Doron Yablecovitch.;Marianne M Amitai.;Yael Haberman.;Limor Selinger.;Adi Talan-Asher.;Ofra Kriger-Sharabi.;Timna Naftali.;Yulia Ron.;Henit Yanai.;Iris Dotan.;Uri Kopylov.;Rami Eliakim.; .
来源: Gastroenterology. 2025年169卷1期85-93.e3页
Optimal treat-to-target strategies for Crohn's disease (CD) are still being sought. The value of video capsule endoscopy (VCE) to guide proactive treat-to-target optimization in CD was examined.

15. A cost-effective measure to prevent hemorrhage in ultrasound-guided percutaneous liver biopsy.

作者: Qingyuan Cai.;Xiaomin Wu.
来源: BMC Gastroenterol. 2025年25卷1期178页
Liver biopsy is a procedure whereby a biopsy needle is used to extract tissue from the liver parenchyma or focal lesions of the liver for pathological or microbiological examination. Percutaneous liver biopsy(PC-LB) is the most commonly employed and least expensive modality. However, it is associated with a significant risk of bleeding complications, which may potentially result in patient mortality. The objective of this study was to investigate the efficacy of Absorbable Gelatin Sponge sheet filler agent (AGS-SFA) in preventing bleeding complications during liver tissue biopsy and to validate a cost-effective surgical technique.

16. A prospective randomized study of the efficacy of continuous active warming in patients undergoing laparoscopic gastrectomy.

作者: Mengjia Luo.;Yanran Dai.;Xiangying Feng.;Yujie Wang.;Xin Guo.;Juan Du.;Gang Ji.;Hongjuan Lang.
来源: BMC Gastroenterol. 2025年25卷1期174页
The RCT study on the efficacy of continuous active warming (CAW) in patients undergoing laparoscopic gastrectomy is scarce. The purpose of this research was to determine if a significant difference between continuous active warming (CAW) and active warming when body temperature is below 36 °C (BAW) in terms of incidence of intraoperative hypothermia and clinical rehabilitation in patients undergoing laparoscopic gastrectomy surgery.

17. Low-residue diet with oral nutritional supplements prior to colonoscopy improves the quality of bowel preparation: an endoscopist-blinded, randomized controlled trial.

作者: Huilin Shen.;Yijie Sun.;Jin Qian.;Jiaqi Wu.;Xueqing Zhong.;Guodong Li.;Weimin Li.
来源: BMC Gastroenterol. 2025年25卷1期166页
Poor bowel preparation has been a great problem of endoscopists for a long time. Low-residue diet (LRD) is often recommended on the day before colonoscopy. However, the quality of bowel preparation with LRD alone is suboptimal. The aim of our study was to examine whether patients who consumed LRD with oral nutritional supplements (ONSs) had higher quality of bowel preparation than patients who consumed LRD alone before colonoscopy.

18. Mebeverine and the Influence of Labeling in Adolescents With Irritable Bowel Syndrome or Functional Abdominal Pain Not Otherwise Specified: A 2 × 2 Randomized, Placebo-Controlled Trial.

作者: Robyn Rexwinkel.;Nicolaas Koen Vermeijden.;Judith Zeevenhooven.;Johannes Kelder.;Michael Groeneweg.;Thalia Hummel.;Joery Goede.;Pamela Hurkmans.;Janneke Stapelbroek.;Marc Benninga.;Arine Vlieger.
来源: Gastroenterology. 2025年169卷1期94-103页
Pediatric irritable bowel syndrome and functional abdominal pain-not otherwise specified lack effective pharmacologic interventions. The efficacy of mebeverine, an antispasmodic agent, and the effect of labeling within a pediatric cohort were evaluated.

19. Effect of montelukast on remission maintenance in patients with ulcerative colitis: a Randomized, double-blind controlled clinical trial.

作者: Kourosh Masnadi Shirazi.;Mehran Nezam Diba.;Arman Masnadi Shirazinezhad.;Zeinab Nikniaz.
来源: BMC Gastroenterol. 2025年25卷1期145页
Considering the role of leukotrienes in inflammatory pathways, and owing to the anti-leukotrienes effect of montelukast, in the present clinical trial, we aimed to assess the effect of montelukast on remission maintenance in patients with ulcerative colitis (UC).

20. The relationships between depression, inflammation and self-reported disease activity in IBD and their impact on healthcare usage.

作者: Natasha Seaton.;Vari Wileman.;Christine Norton.;Joanna Hudson.;Valeria Mondelli.;Rona Moss-Morris.
来源: BMC Gastroenterol. 2025年25卷1期140页
Depression is common in people living with Inflammatory Bowel Disease (IBD). Depression rates increase with active disease and are linked to poorer clinical outcomes. Previous studies investigating the relationship between contemporaneous IBD disease activity and depression are often poorly controlled, use small samples and/or rely on self-reported measures of disease activity. Depression and self-reported disease activity (SRDA) are linked to increased healthcare usage, however, objective inflammation is rarely statistically controlled. The primary aim was to understand how self-reported disease activity and inflammation are related to depression. Secondary aims included assessing the relative influence of self-reported disease activity, inflammation and depression on healthcare usage.
共有 1981 条符合本次的查询结果, 用时 1.3079696 秒